Skip to main content

The Law Offices of Frank R. Cruz Announces Investigation of Stride, Inc. (LRN) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On October 16, 2024, Fuzzy Panda Research published a report alleging, among other things, that Stride has been “misleading investors about a major source of its profits,” estimating that the Company’s Elementary & Secondary School Emergency Relief Funds (“ESSER”) accounted for 26% of 2024 EBITDA and 45% of Net Income and that the “total increase in revenue for Stride Schools from FY 2021-2024 due to ESSER grants alone is >$330 million of revenue.” Additionally, the report stated that Stride “collected taxpayer dollars for kids they were not educating,” with an estimated 5-10% inflation of enrollment numbers due to “Ghost Students.”

On this news, Stride’s stock price fell $6.55, or 9.3%, to close at $64.04 per share on October 16, 2024, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Stride securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.